Health Care & Life Sciences » Pharmaceuticals | Sawai Pharmaceutical Co. Ltd.

Sawai Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
25,536
22,603
33,096
30,771
39,992
57,067
Total Accounts Receivable
28,770
34,118
36,291
41,214
56,206
63,676
Inventories
39,182
44,663
55,668
61,924
65,217
63,449
Other Current Assets
2,566
2,890
3,424
301
733
716
Total Current Assets
96,054
104,274
128,479
134,210
162,149
184,907
Net Property, Plant & Equipment
47,841
54,700
71,843
77,856
88,059
81,233
Total Investments and Advances
3,213
4,662
4,179
5,500
6,149
6,664
Intangible Assets
1,847
2,116
1,496
6,292
96,635
94,537
Other Assets
393
427
495
577
1,170
906
Total Assets
149,348
166,179
206,492
225,609
358,453
372,889
ST Debt & Current Portion LT Debt
2,273
2,563
1,937
1,878
4,993
Accounts Payable
16,157
17,054
22,176
22,475
17,379
Income Tax Payable
4,650
3,222
3,720
1,561
7,383
Other Current Liabilities
16,017
19,369
22,246
29,576
42,520
Total Current Liabilities
39,097
42,208
50,079
55,490
72,275
Long-Term Debt
6,417
10,628
30,032
25,991
80,337
Provision for Risks & Charges
56
45
35
-
-
Deferred Taxes
177
363
87
1,123
4,229
Other Liabilities
2,299
537
539
2,838
3,336
Total Liabilities
48,046
53,781
80,772
84,372
156,011
Common Equity (Total)
101,302
112,398
125,720
141,237
181,350
Total Shareholders' Equity
101,302
112,398
125,720
141,237
181,350
Total Equity
101,302
112,398
125,720
141,237
202,441
Liabilities & Shareholders' Equity
149,348
166,179
206,492
225,609
358,452
Accumulated Minority Interest
-
-
-
-
21,091

About Sawai Pharmaceutical Co.

View Profile
Address
5-2-30 Miyahara
Osaka Osaka 532
Japan
Employees -
Website http://www.sawai.co.jp
Updated 07/08/2019
Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.